SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-061104
Filing Date
2023-11-08
Accepted
2023-11-08 16:10:09
Documents
16
Period of Report
2023-11-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rani-20231108.htm   iXBRL 8-K 49678
2 EX-99.1 rani-ex99_1.htm EX-99.1 252219
3 GRAPHIC img125106939_0.jpg GRAPHIC 30251
4 GRAPHIC img125106939_1.jpg GRAPHIC 31740
5 GRAPHIC img125106939_2.jpg GRAPHIC 19529
  Complete submission text file 0000950170-23-061104.txt   550298

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rani-20231108_pre.xml EX-101.PRE 10303
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rani-20231108_lab.xml EX-101.LAB 14018
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rani-20231108.xsd EX-101.SCH 2493
10 EXTRACTED XBRL INSTANCE DOCUMENT rani-20231108_htm.xml XML 4939
Mailing Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131
Business Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131 (408) 457-3700
Rani Therapeutics Holdings, Inc. (Filer) CIK: 0001856725 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40672 | Film No.: 231387911
SIC: 2834 Pharmaceutical Preparations